Lung CD200 Receptor Activation Abrogates Airway Hyperresponsiveness in Experimental Asthma.
about
A new insight into viral proteins as Immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory proteinControl of local immunity by airway epithelial cells.Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.First genomic analysis of dendritic cells from lung and draining lymph nodes in murine asthmaA Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo.
P2860
Lung CD200 Receptor Activation Abrogates Airway Hyperresponsiveness in Experimental Asthma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lung CD200 Receptor Activation ...... veness in Experimental Asthma.
@en
type
label
Lung CD200 Receptor Activation ...... veness in Experimental Asthma.
@en
prefLabel
Lung CD200 Receptor Activation ...... veness in Experimental Asthma.
@en
P2093
P2860
P356
P1476
Lung CD200 Receptor Activation ...... veness in Experimental Asthma.
@en
P2093
Anick Langlois
Audrey Lee-Gosselin
David Marsolais
Elyse Y Bissonnette
Kim Santerre
Laetitia J A Lai
Ynuk Bossé
P2860
P304
P356
10.1165/RCMB.2014-0229OC
P577
2015-08-01T00:00:00Z